NCT01034748View on ClinicalTrials.gov

A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

[14C]PF00299804

Single 45 mg oral dose of radiolabelled PF-00299804

Trial Locations (1)

98418

Pfizer Investigational Site, Tacoma

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Syneos Health

OTHER

lead

Pfizer

INDUSTRY